Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Phase 2, Double-Blind, Randomized, Controlled Multi-Center Clinical Trial of the Safety and Efficacy of Transplanted Fetal Porcine Cells in Patients With Parkinson's Disease.

This study has been completed.
Diacrin/Genzyme Corporation LLC
Information provided by:
Genzyme, a Sanofi Company Identifier:
First received: September 23, 2005
Last updated: June 18, 2008
Last verified: September 2005
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: January 2001
  Estimated Primary Completion Date: No date given